Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Cammack, N' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 26 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Buss, N; Cammack, N
      Measuring the effectiveness of antiretroviral agents

      ANTIVIRAL THERAPY
    2. Clarysse, C; Lin, L; Crabbe, T; van Pelt, JF; Cammack, N; Yap, SH
      HVR1 quasispecies analysis from a long-term culture of hepatitis C virus in Hep G2 derived cells grown in a haemodialysis cartridge

      JOURNAL OF VIRAL HEPATITIS
    3. Cammack, N
      The potential for HIV fusion inhibition

      CURRENT OPINION IN INFECTIOUS DISEASES
    4. Cammack, N
      Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    5. CLARYSSE C; NEYTS J; DECLERCQ E; CAMMACK N; YAP SH
      SULFATED POLYMERS BUT NOT RIBAVIRIN INTERFERON INHIBIT THE INFECTION IMMORTALIZED HUMAN HEPATOCYTES BY HCV

      Hepatology
    6. CLARYSSE C; LIN L; CRABBE T; VANPELT J; CAMMACK N; YAP SH
      HVR1 SEQUENCES ANALYSIS OF HCV IN LONG-TERM CULTURE OF IMMORTALIZED HUMAN HEPATOCYTES GROWN IN A HEMODIALYSIS CARTRIDGE IN THE PRESENCE OF HCV INOCULUM

      Hepatology
    7. CRAIG C; RACE E; SHELDON J; WHITTAKER L; GILBERT S; MOFFATT A; ROSE J; DISSANAYEKE S; CHIRN GW; DUNCAN IB; CAMMACK N
      HIV PROTEASE GENOTYPE AND VIRAL SENSITIVITY TO HIV PROTEASE INHIBITORS FOLLOWING SAQUINAVIR THERAPY

      AIDS
    8. RACE E; GILBERT SM; SHELDON JG; ROSE JSL; MOFFATT AR; SITBON G; DISSANAYEKE SR; CAMMACK N; DUNCAN IB
      CORRELATION OF RESPONSE TO TREATMENT AND HIV GENOTYPIC CHANGES DURINGPHASE-III TRIALS WITH SAQUINAVIR AND REVERSE-TRANSCRIPTASE INHIBITOR COMBINATION THERAPY

      AIDS
    9. SHARLAND M; WATKINS AM; DALGLEISH AG; CAMMACK N; WESTBY M
      IMMUNE RECONSTITUTION IN HAART-TREATED CHILDREN WITH AIDS

      Lancet
    10. GOULDEN MG; CAMMACK N; HOPEWELL PL; PENN CR; CAMERON JM
      SELECTION IN-VITRO OF AN HIV-1 VARIANT RESISTANT TO BOTH LAMIVUDINE (3TC) AND ZIDOVUDINE

      AIDS
    11. JOHNSON VA; WAGNER SF; OVERBAY CB; WAGNER JR; CAMMACK N; PENN CR; RUBIN M; BARTLETT JA; FALLON MA; QUINN JB; BENOIT SL
      DRUG-RESISTANCE AND VIRAL LOAD IN NUCA-3002 - A COMPARATIVE TRIAL OF LAMIVUDINE (3TC) (HIGH OR LOW DOSE) ZIDOVUDINE (ZDV) COMBINATION THERAPY VS ZDV/DIDEOXYCYTIDINE (DDC) COMBINATION THERAPY IN ZDV-EXPERIENCED(GREATER-THAN-OR-EQUAL-TO-24 WEEKS) PATIENTS (CD4 CELLS 100-300/MM(3))/

      Journal of acquired immune deficiency syndromes and human retrovirology
    12. GAGNON L; NORDSTROM PA; DUCHAINE J; JUTRAS D; HAMEL M; BARBEAU D; HOOKER E; ASHMAN C; CAMMACK N; TSE A; MANSOUR T; YUEN L
      IMMUNOMODULATORY AND ANTIVIRAL ACTIVITIES OF 2',3'-DIDEOXY-BETA-L-CYTIDINE AND 2',3'-DIDEOXY-BETA-L-5-FLUOROCYTIDINE

      Immunopharmacology and immunotoxicology
    13. MANSOUR TS; JIN H; WANG W; DIXIT DM; EVANS CA; TSE HLA; BELLEAU B; GILLARD JW; HOOKER E; ASHMAN C; CAMMACK N; SALOMON H; BELMONTE AR; WAINBERG MA
      STRUCTURE-ACTIVITY-RELATIONSHIPS AMONG A NEW CLASS OF ANTIVIRAL HETEROSUBSTITUTED 2',3'-DIDEOXYNUCLEOSIDE ANALOGS

      Nucleosides & nucleotides
    14. BREINING T; CIMPOIA AR; MANSOUR TS; CAMMACK N; HOPEWELL P; ASHMAN C
      1',2',6'-THIADIAZINE 1',1'-DIOXIDE AND IMIDAZO [4',5'-C] [1',2',6']-THIADIAZINE 2',2'-DIOXODE-1,3-OXATHIOLANE NUCLEOSIDE ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY

      Heterocycles
    15. WAINBERG MA; SALOMON H; GU ZX; MONTANER JSG; COOLEY TP; MCCAFFREY R; RUEDY J; HIRST HM; CAMMACK N; CAMERON J; NICHOLSON W
      DEVELOPMENT OF HIV-1 RESISTANCE TO (-)2'-DEOXY-3'-THIACYTIDINE IN PATIENTS WITH AIDS OR ADVANCED AIDS-RELATED COMPLEX

      AIDS
    16. INGRAND D; WEBER J; BOUCHER CAB; LOVEDAY C; ROBERT C; HILL A; CAMMACK N; KATLAMA C; TUBIANA R; VALENTIN MA; GENTILINI M; VANLEEUWEN R; DANNER SA; KITCHEN V; MCBRIDE M
      PHASE-I PHASE-II STUDY OF 3TC (LAMIVUDINE) IN HIV-POSITIVE, ASYMPTOMATIC OR MILD AIDS-RELATED COMPLEX PATIENTS - SUSTAINED REDUCTION IN VIRAL MARKERS/

      AIDS
    17. WYATT PG; BETHELL RC; CAMMACK N; CHARON D; DODIC N; DUMAITRE B; EVANS DN; GREEN DVS; HOPEWELL PL; HUMBER DC; LAMONT RB; ORR DC; PLESTED SJ; RYAN DM; SOLLIS SL; STORER R; WEINGARTEN GG
      BENZOPHENONE DERIVATIVES - A NOVEL SERIES OF POTENT AND SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE

      Journal of medicinal chemistry
    18. MANSOUR TS; JIN HL; WANG W; HOOKER EU; ASHMAN C; CAMMACK N; SALOMON H; BELMONTE AR; WAINBERG MA
      ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AND ANTI-HEPATITIS-B VIRUS ACTIVITIES AND TOXICITIES OF THE ENANTIOMERS OF 2-DEOXY-3-OXA-4-THIOCYTIDINE AND THEIR 5-FLUORO ANALOGS IN-VITRO

      Journal of medicinal chemistry
    19. HUMBER DC; BAMFORD MJ; BETHELL RC; CAMMACK N; ORR DC; STORER R; WEINGARTEN GG; WYATT PG
      SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF PENICILLIN-DERIVED PSEUDOSYMMETRIC INHIBITORS OF HIV-1 PROTEINASE

      Antiviral chemistry & chemotherapy
    20. KITCHIN J; BETHELL RC; CAMMACK N; DOLAN S; EVANS DN; HOLMAN S; HOLMES DS; MCMEEKIN P; MO CL; NIELAND N; ORR DC; SAUNDERS J; SHENOY BEV; STARKEY ID; STORER R
      SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF PENICILLIN-DERIVED HIV PROTEINASE-INHIBITORS - HETEROCYCLIC RING-SYSTEMS CONTAINING P-1' AND P-2' SUBSTITUENTS

      Journal of medicinal chemistry
    21. GRAY NM; CAMERON JM; CAMMACK N; COBLEY KN; HOLMES DS; HUMBER DC; ORR DC; PENN CR; POTTER R; MADAR S; WEINGARTEN GG; BETHELL RC
      DISCOVERY AND ANALYSIS OF A SERIES OF C-2-SYMMETRICAL HIV-1 PROTEINASE-INHIBITORS DERIVED FROM PENICILLIN

      Analytical biochemistry
    22. GAO Q; GU ZX; PARNIAK MA; CAMERON J; CAMMACK N; BOUCHER C; WAINBERG MA
      THE SAME MUTATION THAT ENCODES LOW-LEVEL HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 RESISTANCE TO 2',3'-DIDEOXYINOSINE AND 2',3'-DIDEOXYCYTIDINE CONFERS HIGH-LEVEL RESISTANCE TO THE (-) ENANTIOMER OF 2',3'-DIDEOXY-3'-THIACYTIDINE

      Antimicrobial agents and chemotherapy
    23. BOUCHER CAB; CAMMACK N; SCHIPPER P; SCHUURMAN R; ROUSE P; WAINBERG MA; CAMERON JM
      HIGH-LEVEL RESISTANCE TO (-) ENANTIOMERIC 2'-DEOXY-3'-THIACYTIDINE IN-VITRO IS DUE TO ONE AMINO-ACID SUBSTITUTION IN THE CATALYTIC SITE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE

      Antimicrobial agents and chemotherapy
    24. LIVERMORE DGH; BETHELL RC; CAMMACK N; HANCOCK AP; HANN MM; GREEN DVS; LAMONT RB; NOBLE SA; ORR DC; PAYNE JJ; RAMSAY MVJ; SHINGLER AH; SMITH C; STORER R; WILLIAMSON C; WILLSON T
      SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF A SERIES OF IMIDAZO[1,5-B]PYRIDAZINES

      Journal of medicinal chemistry
    25. HUMBER DC; BAMFORD MJ; BETHELL RC; CAMMACK N; COBLEY K; EVANS DN; GRAY NM; HANN MM; ORR DC; SAUNDERS J; SHENOY BEV; STORER R; WEINGARTEN GG; WYATT PG
      A SERIES OF PENICILLIN DERIVED C2-SYMMETRICAL INHIBITORS OF HIV-1 PROTEINASE - SYNTHESIS, MODE OF INTERACTION, AND STRUCTURE-ACTIVITY-RELATIONSHIPS

      Journal of medicinal chemistry
    26. HOLMES DS; BETHELL RC; CAMMACK N; CLEMENS IR; KITCHIN J; MCMEEKIN P; MO CL; ORR DC; PATEL B; PATERNOSTER IL; STORER R
      SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF PENICILLIN-DERIVED HIV PROTEINASE-INHIBITORS CONTAINING A STEREOCHEMICALLY UNIQUE PEPTIDE ISOSTERE

      Journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 23:28:17